INTERNATIONAL PATENT: TAKEDA PHARMACEUTICAL COMPANY LIMITED FILES APPLICATION FOR "IMPROVED GIP RECEPTOR AGONIST PEPTIDE COMPOUNDS AND USES THEREOF"

GENEVA, July 29 -- TAKEDA PHARMACEUTICAL COMPANY LIMITED (1-1 Doshomachi 4-ChomeChuo-KuOsaka-Shi, Osaka 541-0045) filed a patent application (PCT/IB2025/050535) for "IMPROVED GIP RECEPTOR AGONIST PEPTIDE COMPOUNDS AND USES THEREOF" on Jan 17, 2025. With publication no. WO/2025/154020, the details related to the patent application was published on Jul 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): COLLIS, Leon (40 Landsdowne St.Cambridge, Massachusetts 02139), HENNIOT, Antoine (9625 Towne Centre Dr.San Diego, California 92121), FALK, Matthew (9625 Towne Centre DriveSan Diego, California ...